CPRX Key Stats
- Catalyst Pharmaceutical Partners to Present at the 26th Annual ROTH Conference noodls 03/06 08:43 ET
- CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD D Yahoo 03/04 17:03 ET
- Catalyst Pharmaceutical Partners Observes Rare Disease Day Today noodls 02/28 08:31 ET
- CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Stat Yahoo 02/20 16:34 ET
- Catalyst Pharmaceutical Partners to Present at 16th Annual BIO CEO & Investor Conference noodls 02/06 09:13 ET
- Catyalyst Pharmaceutical (CPRX) Files $100M Common Shelf Street Insider 02/03 06:43 ET
- 8:03 am Catalyst Pharma reports 'Positive' cardiac safety results of its Phase 3 product, Firdapse tablets; the study met the pre-specified primary endpoint 01/08 17:42 ET
- Aegis Keeps Catalyst Pharm (CPRX) at Buy; New FDA Guidelines Won't Delay Firdapse Street Insider 01/08 12:51 ET
- Catalyst Pharmaceutical Partners Reports Positive Cardiac Safety Results of Its Phase 3 Product, Firdapse Tablets noodls 01/08 08:33 ET
- CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits 01/08 08:24 ET
CPRX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Catalyst Pharmaceutical is up 285.4% over the last year vs S&P 500 Total Return up 24.21%, Jazz Pharmaceuticals up 161.6%, and Forest Laboratories up 146.2%.
Balance Sheet View Statement
Pro Ratings for CPRX
Pro Strategies Featuring CPRX
Did Catalyst Pharmaceutical make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Headquarters Country: United States
- Headquarters State/Province: Florida
- Incorporation Country: United States
- Incorporation State/Province: Delaware
Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical Company, focused on the development and commercialization of prescription drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy.